Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for chest pain in treated achalasia
NL-OMON58857Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in achalasia comparing Citalopram with Placebo (2 arms). Primary endpoint: Global assessment of chest pain relief. Started Oct 2019; status: completed.
02
Drugs
citalopram
03
Conditions
achalasia
Beyond the preview
Go deeper on NL-OMON58857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58857.